Efficacy and Safety of Roxadustat in Patients with Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials including 6,518 Patients

Table 2

Mean change from baseline in iron parameter and lipid levels in DD study.

Parameter	value for heterogeneity (, )	SMD/WMD (95% CI)	value
Hepcidin		-0.12 (-0.39, 0.15)
Iron		1.43 (0.31, 2.55)
Transferrin		3.77 (0.04, 7.50)
Soluble transferrin receptor		0.09 (-0.61, 0.79)
Total iron-binding capacity		2.06 (0.91, 3.22)
Total cholesterol		-0.36 (-1.35, 0.62)
Ferritin		21.33 (3.04, 39.62)
Transferrin saturation	p = 0.46	4.17 (3.90, 4.45)
LDL-cholesterol		-0.64 (-0.73, -0.55)
Triglycerides		-0.09 (-0.39, 0.21)

LDL-cholesterol: low-density lipoprotein cholesterol.